Overactive Bladder
Decreased intravesical ATP in patients with refractory detrusor overactivity and bacteriuria - Abstract
October 23, 2012
MYRBETRIQ™ (mirabegron), overactive bladder treatment from Astellas, now available through U.S. pharmacies
October 22, 2012
Intravesical botulinum type-A toxin (Dysport(®)) in the treatment of idiopathic detrusor overactivity in children - Abstract
October 19, 2012
A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trials - Abstract
October 18, 2012
Trospium chloride once daily for overactive bladder syndrome : Results of a multicenter observational study - Abstract
October 16, 2012
Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes - Abstract
October 15, 2012
Efficacy and adverse events of antimuscarinics for treating overactive bladder: Network meta-analyses - Abstract
October 5, 2012
Cost-effectiveness analysis of antimuscarinic agents for the treatment of overactive bladder - Abstract
October 2, 2012
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection - Abstract
October 1, 2012
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis - Abstract
September 28, 2012
Detrusor myectomy: Long-term functional outcomes - Abstract
September 27, 2012